Enhanced CAR T-cell homing boosts treatment efficacy for osteosarcoma

  • Post author:
  • Post category:uncategorized

Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient’s immune cells to target cancer cells.